Heterogeneous distribution of trastuzumab in HER2-positive xenografts and metastases: role of the tumor microenvironment

Most HER2-positive metastatic breast cancer patients continue to relapse. Incomplete access to all target HER2-positive cells in metastases and tumor tissues is a potential mechanism of resistance to trastuzumab. The location of locally bound trastuzumab was evaluated in HER2-positive tissues in viv...

Descripción completa

Detalles Bibliográficos
Autores principales: Baker, Jennifer Hazel Elizabeth, Kyle, Alastair Hugh, Reinsberg, Stefan Alexander, Moosvi, Firas, Patrick, Haley Margaret, Cran, Jordan, Saatchi, Katayoun, Häfeli, Urs, Minchinton, Andrew Ivor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209006/
https://www.ncbi.nlm.nih.gov/pubmed/30196384
http://dx.doi.org/10.1007/s10585-018-9929-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209006/
https://www.ncbi.nlm.nih.gov/pubmed/30196384
http://dx.doi.org/10.1007/s10585-018-9929-3

Ejemplares similares